Location History:
- Palo Alto, CA (US) (2002)
- Alameda, CA (US) (1998 - 2011)
Company Filing History:
Years Active: 1998-2011
Title: Sheri Miraglia: Innovator in Hematopoietic Stem Cell Research
Introduction
Sheri Miraglia is a prominent inventor based in Alameda, California. She has made significant contributions to the field of hematopoietic stem cell research, holding three patents that focus on specific cell surface antigens and their applications in isolating and characterizing stem cells.
Latest Patents
Her latest patents include a composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment. This invention provides compositions that specifically bind to the AC133 antigen, which is highly tissue-specific. The antigen is detected on a subset of hematopoietic progenitor and stem cells derived from various sources, including human bone marrow and cord blood. The AC133 antigen is recognized as CD34 and contains substantially all of the CFU-GM activity present in the CD34 population. This specificity makes it exceptionally useful for isolating and characterizing human hematopoietic progenitor and stem cells.
Career Highlights
Sheri Miraglia works at Amcell Corporation, where she continues to advance her research in hematopoietic stem cells. Her work has been instrumental in developing reagents that aid in the purification of stem cells, enhancing the understanding of their properties and potential applications in medicine.
Collaborations
Some of her notable coworkers include Amy H Yin and David W Buck, who have collaborated with her on various projects related to stem cell research.
Conclusion
Sheri Miraglia's innovative work in the field of hematopoietic stem cells has paved the way for advancements in medical research and applications. Her contributions are vital for the ongoing exploration of stem cell therapies and their potential to improve human health.